Core Insights - High Tide Inc. ranked No. 182 out of 400 companies in the 2025 Report on Business ranking of Canada's Top Growing Companies, achieving a three-year revenue growth rate of 188% [1][2] - The company previously ranked 87th out of 417 companies in 2024, with a significantly higher three-year growth rate of 486% [2] - High Tide's recent acquisition of Remexian marks a strategic expansion into Europe's largest cannabis market, expected to enhance revenue and create long-term growth opportunities [3] Company Performance - High Tide has been recognized for five consecutive years as one of Canada's Top Growing Companies, reflecting the dedication of its team and the loyalty of its customer base [2][7] - The company operates Canna Cabana, the largest cannabis retail chain in Canada, with 210 locations and a growing market share of 12% [6] - High Tide's subsidiary, Remexian Pharma GmbH, is a key player in the German medical cannabis market, licensed to import from 19 countries, including Canada [7] Industry Context - The Report on Business ranking celebrates innovative businesses in Canada, with 400 companies qualifying through a rigorous application process [4] - The cannabis industry in Canada continues to show significant growth potential, as evidenced by High Tide's performance and expansion efforts [3][6]

MONTREAL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) (“Knight” or “the Company”) is pleased to announce it has ranked No. 384 on the 2025 Report on Business magazine’s ranking of Canada’s Top Growing Companies. Canada’s Top Growing Companies ranks Canadian companies on three-year revenue growth. Knight earned its spot with three-year growth of 53%. “We’re honored to be named one of Canada’s Top Growing Companies by Report on Business for the fifth consecutive year,” said Samira S ...